{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:37Z","timestamp":1792784977357,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"government subsidies from the Federal budget of Russian Federation in accordance with paragraph 4 of article 78.1 of the Budget Code of the Russian Federation","award":["No. 075-15-2020-777"],"award-info":[{"award-number":["No. 075-15-2020-777"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>All forms of dementia including Alzheimer\u2019s disease are currently incurable. Mitochondrial dysfunction and calcium alterations are shown to be involved in the mechanism of neurodegeneration in Alzheimer\u2019s disease. Previously we have described the ability of compound Tg-2112x to protect neurons via sequestration of mitochondrial calcium uptake and we suggest that it can also be protective against neurodegeneration and development of dementia. Using primary co-culture neurons and astrocytes we studied the effect of Tg-2112x and its derivative Tg-2113x on \u03b2-amyloid-induced changes in calcium signal, mitochondrial membrane potential, mitochondrial calcium, and cell death. We have found that both compounds had no effect on \u03b2-amyloid or acetylcholine-induced calcium changes in the cytosol although Tg2113x, but not Tg2112x reduced glutamate-induced calcium signal. Both compounds were able to reduce mitochondrial calcium uptake and protected cells against \u03b2-amyloid-induced mitochondrial depolarization and cell death. Behavioral effects of Tg-2113x on learning and memory in fear conditioning were also studied in 3 mouse models of neurodegeneration: aged (16-month-old) C57Bl\/6j mice, scopolamine-induced amnesia (3-month-old mice), and 9-month-old 5xFAD mice. It was found that Tg-2113x prevented age-, scopolamine- and cerebral amyloidosis-induced decrease in fear conditioning. In addition, Tg-2113x restored fear extinction of aged mice. Thus, reduction of the mitochondrial calcium uptake protects neurons and astrocytes against \u03b2-amyloid-induced cell death and contributes to protection against dementia of different ethology. These compounds could be used as background for the developing of a novel generation of disease-modifying neuroprotective agents.<\/jats:p>","DOI":"10.1038\/s41598-022-16817-9","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T04:48:43Z","timestamp":1659156523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacological sequestration of mitochondrial calcium uptake protects against dementia and \u03b2-amyloid neurotoxicity"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2887-1185","authenticated-orcid":false,"given":"Elena F.","family":"Shevtsova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4596-9117","authenticated-orcid":false,"given":"Plamena R.","family":"Angelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Stelmashchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7938-6131","authenticated-orcid":false,"given":"Noemi","family":"Esteras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2173-6135","authenticated-orcid":false,"given":"Nataliia A.","family":"Vasil\u2019eva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1956-0839","authenticated-orcid":false,"given":"Andrey V.","family":"Maltsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-3680","authenticated-orcid":false,"given":"Pavel N.","family":"Shevtsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4851-4775","authenticated-orcid":false,"given":"Alexander V.","family":"Shaposhnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9080-5763","authenticated-orcid":false,"given":"Vladimir P.","family":"Fisenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3637-818X","authenticated-orcid":false,"given":"Sergey O.","family":"Bachurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7646-7235","authenticated-orcid":false,"given":"Andrey Y.","family":"Abramov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"16817_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(76)91936-x","author":"P Davies","year":"1976","unstructured":"Davies, P. Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet https:\/\/doi.org\/10.1016\/s0140-6736(76)91936-x (1976).","journal-title":"Lancet"},{"key":"16817_CR2","doi-asserted-by":"publisher","first-page":"12845","DOI":"10.1074\/jbc.M808759200","volume":"284","author":"B Frost","year":"2009","unstructured":"Frost, B., Jacks, R. L. & Diamond, M. I. Propagation of Tau Misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845\u201312852. https:\/\/doi.org\/10.1074\/jbc.M808759200 (2009).","journal-title":"J. Biol. Chem."},{"key":"16817_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-v","volume":"12","author":"J Hardy","year":"1991","unstructured":"Hardy, J. & Allsop, D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol. Sci. 12, 383\u2013388. https:\/\/doi.org\/10.1016\/0165-6147(91)90609-v (1991).","journal-title":"Trends Pharmacol. Sci."},{"key":"16817_CR4","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1523\/jneurosci.23-12-05088.2003","volume":"23","author":"AY Abramov","year":"2003","unstructured":"Abramov, A. Y., Canevari, L. & Duchen, M. R. Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J. Neurosci. 23, 5088\u20135095. https:\/\/doi.org\/10.1523\/jneurosci.23-12-05088.2003 (2003).","journal-title":"J. Neurosci."},{"key":"16817_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/med.21712","volume":"41","author":"PR Angelova","year":"2021","unstructured":"Angelova, P. R., Esteras, N. & Abramov, A. Y. Mitochondria and lipid peroxidation in the mechanism of neurodegeneration: Finding ways for prevention. Med. Res. Rev. 41, 770\u2013784. https:\/\/doi.org\/10.1002\/med.21712 (2021).","journal-title":"Med. Res. Rev."},{"key":"16817_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00232-003-0638-7","volume":"197","author":"N Arispe","year":"2004","unstructured":"Arispe, N. Architecture of the Alzheimer\u2019s A beta P ion channel pore. J. Membr. Biol. 197, 33\u201348. https:\/\/doi.org\/10.1007\/s00232-003-0638-7 (2004).","journal-title":"J. Membr. Biol."},{"key":"16817_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1523\/jneurosci.12-02-00376.1992","volume":"12","author":"MP Mattson","year":"1992","unstructured":"Mattson, M. P. et al. Beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376\u2013389. https:\/\/doi.org\/10.1523\/jneurosci.12-02-00376.1992 (1992).","journal-title":"J. Neurosci."},{"key":"16817_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.phrs.2015.05.007","volume":"99","author":"R Abeti","year":"2015","unstructured":"Abeti, R. & Abramov, A. Y. Mitochondrial Ca2+ in neurodegenerative disorders. Pharmacol. Res. 99, 377\u2013381. https:\/\/doi.org\/10.1016\/j.phrs.2015.05.007 (2015).","journal-title":"Pharmacol. Res."},{"key":"16817_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2019.102150","author":"E Britti","year":"2020","unstructured":"Britti, E., Ros, J., Esteras, N. & Abramov, A. Y. Tau inhibits mitochondrial calcium efflux and makes neurons vulnerable to calcium-induced cell death. Cell Calcium https:\/\/doi.org\/10.1016\/j.ceca.2019.102150 (2020).","journal-title":"Cell Calcium"},{"key":"16817_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092135","author":"N Esteras","year":"2020","unstructured":"Esteras, N. & Abramov, A. Y. Mitochondrial calcium deregulation in the mechanism of beta-amyloid and tau pathology. Cells https:\/\/doi.org\/10.3390\/cells9092135 (2020).","journal-title":"Cells"},{"key":"16817_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11813-6","author":"P Jadiya","year":"2019","unstructured":"Jadiya, P. et al. Impaired mitochondrial calcium efflux contributes to disease progression in models of Alzheimer\u2019s disease. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-019-11813-6 (2019).","journal-title":"Nat. Commun."},{"key":"16817_CR12","doi-asserted-by":"publisher","first-page":"e2237","DOI":"10.1038\/cddis.2016.111","volume":"7","author":"R Abeti","year":"2016","unstructured":"Abeti, R. et al. Mitochondrial energy imbalance and lipid peroxidation cause cell death in Friedreich\u2019s ataxia. Cell Death Dis. 7, e2237. https:\/\/doi.org\/10.1038\/cddis.2016.111 (2016).","journal-title":"Cell Death Dis."},{"key":"16817_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.bbamcr.2004.09.006","volume":"1742","author":"AY Abramov","year":"2004","unstructured":"Abramov, A. Y., Canevari, L. & Duchen, M. R. Calcium signals induced by amyloid \u03b2 peptide and their consequences in neurons and astrocytes in culture. Biochimica et Biophysica Acta BBA Mol. Cell Res. 1742, 81\u201387. https:\/\/doi.org\/10.1016\/j.bbamcr.2004.09.006 (2004).","journal-title":"Biochimica et Biophysica Acta BBA Mol. Cell Res."},{"key":"16817_CR14","doi-asserted-by":"publisher","unstructured":"Shevtzova, E. F., Kireeva, E. G. & Bachurin, S. O. Bull. Exp. Biol. Med. 132, 1173\u20131176. https:\/\/doi.org\/10.1023\/a:1014559331402 (2001).","DOI":"10.1023\/a:1014559331402"},{"key":"16817_CR15","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/nm.1868","volume":"14","author":"H Du","year":"2008","unstructured":"Du, H. et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer\u2019s disease. Nat. Med. 14, 1097\u20131105. https:\/\/doi.org\/10.1038\/nm.1868 (2008).","journal-title":"Nat. Med."},{"key":"16817_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16074-2","author":"M Calvo-Rodriguez","year":"2020","unstructured":"Calvo-Rodriguez, M. et al. Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer\u2019s disease. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-020-16074-2 (2020).","journal-title":"Nat. Commun."},{"key":"16817_CR17","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1007\/s12035-018-1204-8","volume":"56","author":"PR Angelova","year":"2019","unstructured":"Angelova, P. R. et al. Pharmacological sequestration of mitochondrial calcium uptake protects neurons against glutamate excitotoxicity. Mol. Neurobiol. 56, 2244\u20132255. https:\/\/doi.org\/10.1007\/s12035-018-1204-8 (2019).","journal-title":"Mol. Neurobiol."},{"key":"16817_CR18","doi-asserted-by":"publisher","first-page":"45627","DOI":"10.1038\/srep45627","volume":"7","author":"SO Bachurin","year":"2017","unstructured":"Bachurin, S. O. et al. Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment. Sci. Rep. 7, 45627. https:\/\/doi.org\/10.1038\/srep45627 (2017).","journal-title":"Sci. Rep."},{"key":"16817_CR19","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.3390\/molecules26185527","volume":"26","author":"SO Bachurin","year":"2021","unstructured":"Bachurin, S. O. et al. Conjugation of aminoadamantane and \u03b3-carboline pharmacophores gives rise to unexpected properties of multifunctional ligands. Molecules 26, 5527 (2021).","journal-title":"Molecules"},{"key":"16817_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/med.21715","volume":"41","author":"EF Shevtsova","year":"2021","unstructured":"Shevtsova, E. F., Maltsev, A. V., Vinogradova, D. V., Shevtsov, P. N. & Bachurin, S. O. Mitochondria as a promising target for developing novel agents for treating Alzheimer\u2019s disease. Med. Res. Rev. 41, 803\u2013827. https:\/\/doi.org\/10.1002\/med.21715 (2021).","journal-title":"Med. Res. Rev."},{"key":"16817_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/1567205011666140505094808","volume":"11","author":"EF Shevtsova","year":"2014","unstructured":"Shevtsova, E. F. et al. Dimebon attenuates the Abeta-induced mitochondrial permeabilization. Curr. Alzheimer Res. 11, 422\u2013429. https:\/\/doi.org\/10.2174\/1567205011666140505094808 (2014).","journal-title":"Curr. Alzheimer Res."},{"key":"16817_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12035-017-0745-6","volume":"55","author":"T Strekalova","year":"2018","unstructured":"Strekalova, T. et al. Pro-neurogenic, memory-enhancing and anti-stress effects of DF302, a novel fluorine gamma-carboline derivative with multi-target mechanism of action. Mol. Neurobiol. 55, 335\u2013349. https:\/\/doi.org\/10.1007\/s12035-017-0745-6 (2018).","journal-title":"Mol. Neurobiol."},{"key":"16817_CR23","doi-asserted-by":"publisher","first-page":"5315","DOI":"10.2174\/0929867323666160804122746","volume":"25","author":"A Ustyugov","year":"2018","unstructured":"Ustyugov, A. et al. New therapeutic property of dimebon as a neuroprotective agent. Curr. Med. Chem. 25, 5315\u20135326. https:\/\/doi.org\/10.2174\/0929867323666160804122746 (2018).","journal-title":"Curr. Med. Chem."},{"key":"16817_CR24","doi-asserted-by":"publisher","first-page":"S243","DOI":"10.1016\/S0924-977X(06)70205-X","volume":"16","author":"EP Shevtsova","year":"2006","unstructured":"Shevtsova, E. P., Dubova, L. G., Kireeva, E. G. & Bachurin, S. O. Mitochondria as the memantine target. Eur. Neuropsychopharmacol. 16, S243\u2013S244. https:\/\/doi.org\/10.1016\/S0924-977X(06)70205-X (2006).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"16817_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1517\/17460441.2015.1041913","volume":"10","author":"D Puzzo","year":"2015","unstructured":"Puzzo, D., Gulisano, W., Palmeri, A. & Arancio, O. Rodent models for Alzheimer\u2019s disease drug discovery. Expert Opin. Drug Discov. 10, 703\u2013711. https:\/\/doi.org\/10.1517\/17460441.2015.1041913 (2015).","journal-title":"Expert Opin. Drug Discov."},{"key":"16817_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-3-319-28383-8_21","volume":"12","author":"RA Bekdash","year":"2016","unstructured":"Bekdash, R. A. Choline and the brain: An epigenetic perspective. Adv. Neurobiol. 12, 381\u2013399. https:\/\/doi.org\/10.1007\/978-3-319-28383-8_21 (2016).","journal-title":"Adv. Neurobiol."},{"key":"16817_CR27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ejphar.2012.03.009","volume":"683","author":"Z Dong","year":"2012","unstructured":"Dong, Z. & Fu, A. Prevention of age-related memory deficit in transgenic mice by human choline acetyltransferase. Eur. J. Pharmacol. 683, 174\u2013178. https:\/\/doi.org\/10.1016\/j.ejphar.2012.03.009 (2012).","journal-title":"Eur. J. Pharmacol."},{"key":"16817_CR28","doi-asserted-by":"crossref","unstructured":"Friedman, E. et al. in Alzheimer\u2019s and Parkinson\u2019s Disease Advances in Behavioral Biology Ch. Chapter 47, 393\u2013405 (1986).","DOI":"10.1007\/978-1-4613-2179-8_47"},{"key":"16817_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010079","author":"H Rottenberg","year":"2021","unstructured":"Rottenberg, H. & Hoek, J. B. The mitochondrial permeability transition: nexus of aging, disease and longevity. Cells https:\/\/doi.org\/10.3390\/cells10010079 (2021).","journal-title":"Cells"},{"key":"16817_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/BF00216073","volume":"96","author":"WS Stone","year":"1988","unstructured":"Stone, W. S., Croul, C. E. & Gold, P. E. Attenuation of scopolamine-induced amnesia in mice. Psychopharmacology 96, 417\u2013420. https:\/\/doi.org\/10.1007\/BF00216073 (1988).","journal-title":"Psychopharmacology"},{"key":"16817_CR31","doi-asserted-by":"publisher","first-page":"9748","DOI":"10.1038\/srep09748","volume":"5","author":"R Bajo","year":"2015","unstructured":"Bajo, R. et al. Scopolamine effects on functional brain connectivity: A pharmacological model of Alzheimer\u2019s disease. Sci. Rep. 5, 9748. https:\/\/doi.org\/10.1038\/srep09748 (2015).","journal-title":"Sci. Rep."},{"key":"16817_CR32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1177\/1533317517715906","volume":"32","author":"IM Balmus","year":"2017","unstructured":"Balmus, I. M. & Ciobica, A. Main plant extracts\u2019 active properties effective on scopolamine-induced memory loss. Am. J. Alzheimers Dis. Other Demen. 32, 418\u2013428. https:\/\/doi.org\/10.1177\/1533317517715906 (2017).","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"16817_CR33","doi-asserted-by":"publisher","first-page":"796","DOI":"10.14348\/molcells.2015.0116","volume":"38","author":"H-J Kim","year":"2015","unstructured":"Kim, H.-J. et al. Oral administration of gintonin attenuates cholinergic impairments by scopolamine, amyloid-\u03b2 protein, and mouse model of alzheimer\u2019s disease. Mol. Cells 38, 796\u2013805. https:\/\/doi.org\/10.14348\/molcells.2015.0116 (2015).","journal-title":"Mol. Cells"},{"key":"16817_CR34","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ptr.5804","volume":"31","author":"JY Seo","year":"2017","unstructured":"Seo, J. Y., Lim, S. S., Kim, J., Lee, K. W. & Kim, J.-S. Alantolactone and isoalantolactone prevent amyloid \u03b225\u201335-induced toxicity in mouse cortical neurons and scopolamine-induced cognitive impairment in mice. Phytother. Res. 31, 801\u2013811. https:\/\/doi.org\/10.1002\/ptr.5804 (2017).","journal-title":"Phytother. Res."},{"key":"16817_CR35","doi-asserted-by":"publisher","first-page":"15032","DOI":"10.1038\/srep15032","volume":"5","author":"Y Wu","year":"2015","unstructured":"Wu, Y. et al. Intraperitoneal administration of a novel TAT-BDNF peptide ameliorates cognitive impairments via modulating multiple pathways in two alzheimer\u2019s rodent models. Sci. Rep. 5, 15032. https:\/\/doi.org\/10.1038\/srep15032 (2015).","journal-title":"Sci. Rep."},{"key":"16817_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032082","volume":"7","author":"SK Falsafi","year":"2012","unstructured":"Falsafi, S. K., Deli, A., Hoger, H., Pollak, A. & Lubec, G. Scopolamine administration modulates muscarinic, nicotinic and NMDA receptor systems. PLoS ONE 7, e32082. https:\/\/doi.org\/10.1371\/journal.pone.0032082 (2012).","journal-title":"PLoS ONE"},{"key":"16817_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/2398212819848213","author":"TVP Bliss","year":"2019","unstructured":"Bliss, T. V. P. & Collingridge, G. L. Persistent memories of long-term potentiation and the N-methyl-d-aspartate receptor. Brain Neurosci. Adv. https:\/\/doi.org\/10.1177\/2398212819848213 (2019).","journal-title":"Brain Neurosci. Adv."},{"key":"16817_CR38","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/s0006-8993(96)00404-0","volume":"725","author":"H Li","year":"1996","unstructured":"Li, H. NMDA-but not AMPA-receptor antagonists augment scopolamine-induced spatial cognitive deficit of rats in a radial maze task. Brain Res. 725, 268\u2013271. https:\/\/doi.org\/10.1016\/s0006-8993(96)00404-0 (1996).","journal-title":"Brain Res."},{"key":"16817_CR39","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10519-006-9118-z","volume":"37","author":"JL Eriksen","year":"2007","unstructured":"Eriksen, J. L. & Janus, C. G. Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behav. Genet. 37, 79\u2013100. https:\/\/doi.org\/10.1007\/s10519-006-9118-z (2007).","journal-title":"Behav. Genet."},{"issue":"196","key":"16817_CR40","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A. & Wirths, O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u03b2 aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol. Aging 33(196), e129-196.e140. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.05.027 (2012).","journal-title":"Neurobiol. Aging"},{"key":"16817_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1460-9568.2009.07031.x","volume":"31","author":"L Devi","year":"2010","unstructured":"Devi, L. & Ohno, M. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer\u2019s disease model mice. Eur. J. Neurosci. 31, 110\u2013118. https:\/\/doi.org\/10.1111\/j.1460-9568.2009.07031.x (2010).","journal-title":"Eur. J. Neurosci."},{"key":"16817_CR42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/hipo.22267","volume":"24","author":"SD Girard","year":"2014","unstructured":"Girard, S. D. et al. Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer\u2019s disease. Hippocampus 24, 762\u2013772. https:\/\/doi.org\/10.1002\/hipo.22267 (2014).","journal-title":"Hippocampus"},{"key":"16817_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.nlm.2009.05.001","volume":"92","author":"M Ohno","year":"2009","unstructured":"Ohno, M. Failures to reconsolidate memory in a mouse model of Alzheimer\u2019s disease. Neurobiol. Learn Mem. 92, 455\u2013459. https:\/\/doi.org\/10.1016\/j.nlm.2009.05.001 (2009).","journal-title":"Neurobiol. Learn Mem."},{"key":"16817_CR44","first-page":"897","volume":"17","author":"SO Bachurin","year":"1996","unstructured":"Bachurin, S. O., Shevtzova, E. P., Lermontova, N. N., Serkova, T. P. & Ramsay, R. R. The effect of dithiocarbamates on neurotoxic action of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and on mitochondrial respiration chain. Neurotoxicology 17, 897\u2013903 (1996).","journal-title":"Neurotoxicology"},{"key":"16817_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0014-5793(76)80434-6","volume":"68","author":"KE Akerman","year":"1976","unstructured":"Akerman, K. E. & Wikstr\u00f6m, M. K. Safranine as a probe of the mitochondrial membrane potential. FEBS Lett. 68, 191\u2013197. https:\/\/doi.org\/10.1016\/0014-5793(76)80434-6 (1976).","journal-title":"FEBS Lett."},{"key":"16817_CR46","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.bcp.2014.01.011","volume":"88","author":"D Puzzo","year":"2014","unstructured":"Puzzo, D., Lee, L., Palmeri, A., Calabrese, G. & Arancio, O. Behavioral assays with mouse models of Alzheimer\u2019s disease: Practical considerations and guidelines. Biochem. Pharmacol. 88, 450\u2013467. https:\/\/doi.org\/10.1016\/j.bcp.2014.01.011 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"16817_CR47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.euroneuro.2013.06.010","volume":"24","author":"J Vignisse","year":"2014","unstructured":"Vignisse, J. et al. Concomitant manipulation of murine NMDA- and AMPA-receptors to produce pro-cognitive drug effects in mice. Eur. Neuropsychopharmacol. 24, 309\u2013320. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.06.010 (2014).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"16817_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/596126","volume":"2015","author":"JP Costa-Nunes","year":"2015","unstructured":"Costa-Nunes, J. P. et al. Animal models of depression and drug delivery with food as an effective dosing method: evidences from studies with celecoxib and dicholine succinate. Biomed. Res. Int. 2015, 596126. https:\/\/doi.org\/10.1155\/2015\/596126 (2015).","journal-title":"Biomed. Res. Int."},{"key":"16817_CR49","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/aps.2009.64","volume":"30","author":"J-X Shen","year":"2009","unstructured":"Shen, J.-X. & Yakel, J. L. Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacol. Sin. 30, 673\u2013680. https:\/\/doi.org\/10.1038\/aps.2009.64 (2009).","journal-title":"Acta Pharmacol. Sin."},{"key":"16817_CR50","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/1873-3468.12964","volume":"592","author":"PR Angelova","year":"2018","unstructured":"Angelova, P. R. & Abramov, A. Y. Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett. 592, 692\u2013702. https:\/\/doi.org\/10.1002\/1873-3468.12964 (2018).","journal-title":"FEBS Lett."},{"key":"16817_CR51","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s11172-016-1461-5","volume":"65","author":"VB Sokolov","year":"2017","unstructured":"Sokolov, V. B. et al. Molecular design of multitarget neuroprotectors 3. Synthesis and bioactivity of tetrahydrocarbazole\u2013aminoadamantane conjugates. Russian Chem. Bull. 65, 1354\u20131359. https:\/\/doi.org\/10.1007\/s11172-016-1461-5 (2017).","journal-title":"Russian Chem. Bull."},{"key":"16817_CR52","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1474-9726.2011.00685.x","volume":"10","author":"AY Abramov","year":"2011","unstructured":"Abramov, A. Y., Ionov, M., Pavlov, E. & Duchen, M. R. Membrane cholesterol content plays a key role in the neurotoxicity of \u03b2-amyloid: Implications for Alzheimer\u2019s disease. Aging Cell 10, 595\u2013603. https:\/\/doi.org\/10.1111\/j.1474-9726.2011.00685.x (2011).","journal-title":"Aging Cell"},{"key":"16817_CR53","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1021\/bi401606f","volume":"53","author":"P Narayan","year":"2014","unstructured":"Narayan, P. et al. Rare individual amyloid-\u03b2 oligomers act on astrocytes to initiate neuronal damage. Biochemistry 53, 2442\u20132453. https:\/\/doi.org\/10.1021\/bi401606f (2014).","journal-title":"Biochemistry"},{"key":"16817_CR54","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1523\/jneurosci.4042-03.2004","volume":"24","author":"AY Abramov","year":"2004","unstructured":"Abramov, A. Y. Amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J. Neurosci. 24, 565\u2013575. https:\/\/doi.org\/10.1523\/jneurosci.4042-03.2004 (2004).","journal-title":"J. Neurosci."},{"key":"16817_CR55","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1042\/bst20140153","volume":"42","author":"PR Angelova","year":"2014","unstructured":"Angelova, P. R. & Abramov, A. Y. Interaction of neurons and astrocytes underlies the mechanism of A\u03b2-induced neurotoxicity. Biochem. Society Trans. 42, 1286\u20131290. https:\/\/doi.org\/10.1042\/bst20140153 (2014).","journal-title":"Biochem. Society Trans."},{"key":"16817_CR56","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0143-4160(02)00203-8","volume":"33","author":"AY Abramov","year":"2003","unstructured":"Abramov, A. Y. & Duchen, M. R. Actions of ionomycin, 4-Br A23187 and a novel electrogenic Ca2+ ionophore on mitochondria in intact cells. Cell Calcium 33, 101\u2013112. https:\/\/doi.org\/10.1016\/s0143-4160(02)00203-8 (2003).","journal-title":"Cell Calcium"},{"key":"16817_CR57","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0143-4160(97)90062-2","volume":"22","author":"MV Zamaraeva","year":"1997","unstructured":"Zamaraeva, M. V. et al. Ionophoretic properties of ferutinin. Cell Calcium 22, 235\u2013241. https:\/\/doi.org\/10.1016\/s0143-4160(97)90062-2 (1997).","journal-title":"Cell Calcium"},{"key":"16817_CR58","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jphysparis.2014.04.005","volume":"108","author":"MG Blake","year":"2014","unstructured":"Blake, M. G., Krawczyk, M. C., Baratti, C. M. & Boccia, M. M. Neuropharmacology of memory consolidation and reconsolidation: Insights on central cholinergic mechanisms. J. Physiol. Paris 108, 286\u2013291. https:\/\/doi.org\/10.1016\/j.jphysparis.2014.04.005 (2014).","journal-title":"J. Physiol. Paris"},{"key":"16817_CR59","doi-asserted-by":"publisher","first-page":"a006320","DOI":"10.1101\/cshperspect.a006320","volume":"2","author":"FM LaFerla","year":"2012","unstructured":"LaFerla, F. M. & Green, K. N. Animal models of alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006320. https:\/\/doi.org\/10.1101\/cshperspect.a006320 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"16817_CR60","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1476-5381.2011.01299.x","volume":"164","author":"D Van Dam","year":"2011","unstructured":"Van Dam, D. & De Deyn, P. P. Animal models in the drug discovery pipeline for Alzheimer\u2019s disease. Br. J. Pharmacol. 164, 1285\u20131300. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01299.x (2011).","journal-title":"Br. J. Pharmacol."},{"key":"16817_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10072-015-2441-5","volume":"37","author":"M El Haj","year":"2016","unstructured":"El Haj, M. Memory suppression in Alzheimer\u2019s disease. Neurol. Sci. 37, 337\u2013343. https:\/\/doi.org\/10.1007\/s10072-015-2441-5 (2016).","journal-title":"Neurol. Sci."},{"key":"16817_CR62","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbr.2005.06.040","volume":"165","author":"T Gould","year":"2005","unstructured":"Gould, T. & Feiro, O. Age-related deficits in the retention of memories for cued fear conditioning are reversed by galantamine treatment. Behav. Brain Res. 165, 160\u2013171. https:\/\/doi.org\/10.1016\/j.bbr.2005.06.040 (2005).","journal-title":"Behav. Brain Res."},{"key":"16817_CR63","doi-asserted-by":"publisher","first-page":"247","DOI":"10.31887\/DCNS.2000.2.3\/cgilles","volume":"2","author":"C Gilles","year":"2000","unstructured":"Gilles, C. & Ertle, S. Pharmacological models in Alzheimer\u2019s disease research. Dialogues Clin. Neurosci. 2, 247\u2013255 (2000).","journal-title":"Dialogues Clin. Neurosci."},{"key":"16817_CR64","first-page":"564","volume":"65","author":"AB Zuzina","year":"2015","unstructured":"Zuzina, A. B. & Balaban, P. M. Extinction and reconsolidation of memory. Zh Vyssh Nerv Deiat Im I P Pavlova 65, 564\u2013576 (2015).","journal-title":"Zh Vyssh Nerv Deiat Im I P Pavlova"},{"key":"16817_CR65","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s002130050745","volume":"140","author":"JA Harris","year":"1998","unstructured":"Harris, J. A. & Westbrook, R. F. Evidence that GABA transmission mediates context-specific extinction of learned fear. Psychopharmacology 140, 105\u2013115. https:\/\/doi.org\/10.1007\/s002130050745 (1998).","journal-title":"Psychopharmacology"},{"key":"16817_CR66","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/j.neubiorev.2011.12.014","volume":"36","author":"CA Orsini","year":"2012","unstructured":"Orsini, C. A. & Maren, S. Neural and cellular mechanisms of fear and extinction memory formation. Neurosci. Biobehav. Rev. 36, 1773\u20131802. https:\/\/doi.org\/10.1016\/j.neubiorev.2011.12.014 (2012).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"16817_CR67","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.nlm.2014.11.014","volume":"118","author":"SD Schmidt","year":"2015","unstructured":"Schmidt, S. D. et al. PACAP modulates the consolidation and extinction of the contextual fear conditioning through NMDA receptors. Neurobiol. Learn. Mem. 118, 120\u2013124. https:\/\/doi.org\/10.1016\/j.nlm.2014.11.014 (2015).","journal-title":"Neurobiol. Learn. Mem."},{"key":"16817_CR68","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.brainres.2014.10.010","volume":"1621","author":"S Maren","year":"2015","unstructured":"Maren, S. Out with the old and in with the new: Synaptic mechanisms of extinction in the amygdala. Brain Res. 1621, 231\u2013238. https:\/\/doi.org\/10.1016\/j.brainres.2014.10.010 (2015).","journal-title":"Brain Res."},{"key":"16817_CR69","doi-asserted-by":"publisher","first-page":"17213","DOI":"10.1073\/pnas.0508575102","volume":"102","author":"NH Greig","year":"2005","unstructured":"Greig, N. H. et al. Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer-amyloid peptide in rodent. Proc. Natl. Acad. Sci. 102, 17213\u201317218. https:\/\/doi.org\/10.1073\/pnas.0508575102 (2005).","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16817-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16817-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16817-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T23:50:22Z","timestamp":1669333822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-16817-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["16817"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-16817-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"16 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12766"}}